260
Participants
Start Date
May 31, 2006
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2011
mechlorethamine-MCH (nitrogen mustard)
All affected areas (lesions) are to be treated once daily for twelve months with mechlorethamine-MCH (nitrogen mustard) 0.02% PG or NM 0.02% AP ointment
NYU Medical Center Dept. of Dermatology, New York
Columbia University, Dept. of Dermatology, New York
University of Pennsylvania, Philadelphia
Duke University Medical Center, Durham
University of Wisconsin, Madison
Northwestern University - Dept. of Dermatology, Chicago
Oklahoma University, Tulsa
University of Texas, Southwestern Medical Center, Dallas
The University of Texas, M.D. Anderson Cancer Center, Houston
Utah Clinical Trials, LLC, Salt Lake City
Stanford University Medical Center, Stanford
Fox Chase Cancer Center, Philadelphia
Lead Sponsor
Yaupon Therapeutics
INDUSTRY